Full-Time
Confirmed live in the last 24 hours
Global biopharmaceutical firm focused on R&D
No salary listed
Senior, Expert
Bengaluru, Karnataka, India
This role is considered a hybrid position, and candidates must be able to work onsite at Takeda, ICC Bangalore office to engage in meaningful in-person interactions.
Upload your resume to see how it matches 12 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda collaborates with around 41,000 suppliers worldwide to ensure the production and distribution of its medicines. Unlike many competitors, Takeda emphasizes patient-centric values, placing the needs of patients at the core of its operations. Additionally, the company is committed to environmental sustainability, recognizing the connection between environmental health and human health. Takeda's goal is to provide life-changing therapies while maintaining a focus on innovation and long-term growth.
Company Size
10,001+
Company Stage
IPO
Headquarters
Tokyo, Japan
Founded
1781
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Wellness Program
Tuition Reimbursement
( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.
Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.
ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.
Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.
VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...